Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Saliva Diagnostic Systems, now operating as StatSure Diagnostic Systems, is a medical technology company specializing in the development and manufacture of saliva-based diagnostic tools and rapid immunoassays. Founded in 1990, the company pioneered non-invasive oral fluid collection and testing, notably developing the "barrel" technology used in rapid HIV tests. Its flagship products include the StatSure HIV test (marketed as SURE CHECK) and various oral fluid collection devices like Quantisal and Saliva-Sampler. The company has established significant partnerships with major diagnostic players such as Chembio and Inverness Medical (now Abbott) to commercialize its patented technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Saliva Diagnostic Systems.